PROGNOSTIC-SIGNIFICANCE OF HER-2/NEU ONCOPROTEIN EXPRESSION IN NODE-POSITIVE BREAST-CANCER

被引:0
|
作者
TETU, B
BRISSON, J
POTVIN, D
MARTEL, D
机构
[1] UNIV LAVAL,CTR RECH CANC,DEPT PATHOL,QUEBEC CITY G1K 7P4,QUEBEC,CANADA
[2] UNIV LAVAL,RECH EPIDEMIOL GRP,QUEBEC CITY G1K 7P4,QUEBEC,CANADA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:A20 / A20
页数:1
相关论文
共 50 条
  • [21] COEXPRESSION OF HER-2/NEU AND P53 IS ASSOCIATED WITH A SHORTER DISEASE-FREE SURVIVAL IN NODE-POSITIVE BREAST-CANCER PATIENTS
    WILTSCHKE, C
    KINDASMUEGGE, I
    STEININGER, A
    REINER, A
    REINER, G
    PREIS, PN
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (12) : 737 - 742
  • [22] Expression and prognostic value of HER-2/neu in primary breast cancer with sentinel lymph node metastasis
    Tong, Zhen-Jun
    Shi, Ning-Yao
    Zhang, Zhi-Ji
    Yuan, Xiao-Dong
    Hong, Xiao-Ming
    BIOSCIENCE REPORTS, 2017, 37
  • [23] PROGNOSTIC-SIGNIFICANCE OF THE IMMUNOHISTOCHEMICAL REACTION TO HUMAN-MILK FAT GLOBULE ANTIBODIES IN NODE-NEGATIVE AND NODE-POSITIVE BREAST-CANCER
    STERNS, EE
    FLETCHER, WA
    ZEE, B
    BREAST CANCER RESEARCH AND TREATMENT, 1992, 21 (03) : 193 - 199
  • [24] PREDICTION OF RESPONSE TO ADJUVANT CHEMOTHERAPY IN PREMENOPAUSAL LYMPH-NODE POSITIVE BREAST-CANCER PATIENTS WITH MORPHOMETRY, DNA FLOW-CYTOMETRY AND HER-2 NEU ONCOPROTEIN EXPRESSION
    VANDIEST, PJ
    BAAK, JPA
    MATZECOK, P
    BACUS, SS
    PATHOLOGY RESEARCH AND PRACTICE, 1992, 188 (03) : 344 - 349
  • [25] VARIABLE EXPRESSION OF EGFR AND HER-2/NEU IN PRIMARY AND METASTATIC BREAST-CANCER
    LOWER, EE
    HEFFELFINGER, SC
    MILLER, MA
    FENOGLIOPREISER, CM
    CLINICAL RESEARCH, 1994, 42 (03): : A424 - A424
  • [26] HER-2 NEU ONCOGENE EXPRESSION AND DNA PLOIDY ANALYSIS IN BREAST-CANCER
    BACUS, SS
    BACUS, JW
    SLAMON, DJ
    PRESS, MF
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (02) : 164 - 169
  • [27] Expression and Significance of HER-2/neu and RECK Proteins in Breast Cancer Tissue
    Shen Bo
    Wei Da
    Xu Xinyu
    Zheng Maqing
    Feng Jifeng
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (03): : 76 - 78
  • [28] Comparison of Nodal versus Primary Her2/neu Expression in Node-positive Breast Cancer Patients
    Lago-Toro, C. E.
    Grujic, E.
    Larsen, A. R.
    Allen, L.
    Barrio, A. V.
    Sieling, B.
    Fancher, T.
    Frazier, T. G.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 : S52 - S52
  • [29] CLINICAL-SIGNIFICANCE OF HER-2/NEU ONCOGENE AMPLIFICATION IN PRIMARY BREAST-CANCER
    SESHADRI, R
    FIRGAIRA, FA
    HORSFALL, DJ
    MCCAUL, K
    SETLUR, V
    KITCHEN, P
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1936 - 1942
  • [30] Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer
    Kohlberger, P
    Loesch, A
    Koelbl, H
    Breitenecker, G
    Kainz, C
    Gitsch, G
    CANCER LETTERS, 1996, 98 (02) : 151 - 155